How to Read a CJC-1295 + Ipamorelin Certificate of Analysis (COA)
A Certificate of Analysis is only useful if you know which number on it matters for the compound in front of you. For CJC-1295 + Ipamorelin, the informative checks are not the same as for a generic short peptide.
In plain English
A blend report should identify both components separately and state the ratio between them. A single purity figure for a two-part product is genuinely uninformative — it can tell you the vial is 99% peptide while saying nothing about whether the two are in the right proportion, which is the specific thing that goes wrong with mixtures.
What CJC-1295 + Ipamorelin actually is
This is a blend of two separate molecules rather than one. CJC-1295 is a shortened version of the natural growth hormone signal with four amino acids swapped for resistance. Ipamorelin works through a completely different receptor. They are paired because they reach the same result by two independent routes.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Assays that are informative for CJC-1295 + Ipamorelin
What to check on the COA
A blend COA should resolve and report BOTH components, ideally with a ratio. A single purity figure for a two-component product is uninformative — it cannot tell you whether the ratio is correct. Look for two identified peaks on the chromatogram and two confirmed molecular ions.
Component ratio deviation is the characteristic quality issue for blends, alongside the usual synthesis-related impurities of each component.
Verify a Popular Peptides batch
Every batch is third-party tested by HPLC and LC-MS with a published Certificate of Analysis (≥99% purity). Enter a lot number to pull the COA for the exact vial in front of you.
What CJC-1295 + Ipamorelin is studied for
GHRH-receptor and ghrelin-receptor agonism act through different mechanisms, which is the rationale for pairing them.
Developed specifically for GH release with minimal cortisol and prolactin effects — its defining pharmacological feature.
Studied for effects on the pattern of GH secretion rather than continuous elevation.
A common endpoint in the preclinical literature for GH-axis compounds.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More CJC-1295 + Ipamorelin reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Purity & COA reference for other compounds
CJC-1295 + Ipamorelin is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.